Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism
Open accessThe DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
The conversion of testosterone into dihydrotestosterone by steroid 5 alpha-reductase is a key reaction in androgen action, and is essential both for the formation of the male phenotype during embryogenesis and for androgen-mediated growth of tissues such as the prostate. Single gene defects that impair this conversion lead to pseudohermaphroditism in which 46X,Y males have male internal urogenital tracts, but female external genitalia. We have described the isolation of a human 5 alpha-reductase complementary DNA from prostate. Subsequent cloning and genetic studies showed that this gene (designated 5 alpha-reductase 1) was normal in patients with 5 alpha-reductase deficiency. We report here the isolation of a second 5 alpha-reductase cDNA by expression cloning and the polymerase chain reaction. The biochemical and pharmacological properties of this cDNA-encoded enzyme (designated 5 alpha-reductase 2) are consistent with it being the major isozyme in genital tissue. A deletion in this gene is present in two related individuals with male pseudohermaphroditism caused by 5 alpha-reductase deficiency. These results verify the existence of at least two 5 alpha-reductases in man and provide insight into a fundamental hormone-mediated event in male sexual differentiation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Androgens and in particular the intraprostatic conversion of circulating T to DHT by SRD5A2 (Russell and Wilson, 1994) are required for normal prostate development and function (Andersson et al., 1991, Imperato-McGinley et al., 1974).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Andersson et al., 1991
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Church, G. M., & Gilbert, W. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.7.1991 · Cited by 8,116
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,786
The Metabolic Basis of Inherited Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-389_2 · Cited by 3,983
Shinozaki, K., Ohme, M., Tanaka, M., Wakasugi, T., Hayashida, N., Matsubayashi, T., Zaita, N., Chunwongse, J., Obokata, J., Yamaguchi-Shinozaki, K., et al. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04464.x · Cited by 2,403
Andersson, S., Davis, D. L., Dahlbäck, H., Jörnvall, H., & Russell, D. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83172-6 · Cited by 1,229
Self-citationA regulatory hierarchy for cell specialization in yeast
Herskowitz, I. (1989) · Nature · doi:10.1038/342749a0 · Cited by 590
Research works printed but not linked: 4
- Wilson, J. D. Harvey Lect. 79, 145–172 (1985).
- Wilson, J. D. Endocrinology 25, 491–508 (1975).
- Gorman, C. M., Gies, D. R. & McCray, G. DNA Prot. Engng. Tech. 2, 3–10 (1990).
- Jenkins, E. P., Andersson, S., Imperato-McGinley, J., Wilson, J. D. & Russell, D. W. J. clin. Invest. (in the press).
Cited by
Items 201–300 of 650
Steroid Sulfatase in the Human Hair Follicle Concentrates in the Dermal Papilla
Hoffmann, R., Niiyama, S., Rot, A., & Billich, A. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01547.x · Cited by 66
Kantoff, P. W., Febbo, P. G., Giovannucci, E. L., Krithivas, K., Dahl, D. M., Chang, G. T. G., Hennekens, C. H., Brown, M., & Stampfer, M. J. (1997) · PubMed · Cited by 61
Steroid Hormones and the Development of Reproductive Organs
Morohashi, K.-I., Baba, T., & Tanaka, M. (2012) · Sexual Development · doi:10.1159/000342272 · Cited by 65
“…in the above-mentioned genes have been found to induce abnormal male development ( StAR [Tee et al., 1995]; CYP11A1 [Katsumata et al., 2002]; HSD3B2 [Simard et al., 1994]; CYP17A1 [Kagimoto et al., 1988]; HSD17B3 [Moghrabi et al., 1998]; SRD5A2 [Andersson et al., 1991]; POR [Fluck et al., 2004]).”
Natural potent androgens: Lessons from human genetic models
Zhu, Y., Katz, M. D., & Imperato‐McGinley, J. (1998) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(98)80478-3 · Cited by 66
Disorders of sexual development in the dog and cat
Lyle, S. K. (2007) · Theriogenology · doi:10.1016/j.theriogenology.2007.04.015 · Cited by 60
Hiort, O., Willenbring, H., Albers, N., Hecker, W., Engert, J., DIBBELT, L., & Sinnecker, G. H. G. (1996) · European Journal of Pediatrics · doi:10.1007/bf01955179 · Cited by 60
Androgen Metabolism in Men Receiving Finasteride before Prostatectomy
Norman, R. W., Coakes, K. E., Wright, A. S., & Rittmaster, R. S. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35882-2 · Cited by 61
Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism
Tartagni, M., Schonäuer, L. M., Salvia, M. A. D., Cicinelli, E., Pergola, G. D., & D’Addario, V. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00633-0 · Cited by 59
A potential paradox in prostate adenocarcinoma progression: Oestrogen as the initiating driver
Singh, P. B., Matanhelia, S. S., & Martin, F. L. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.051 · Cited by 66
“There is a profound reduction in prostatic morphogenesis and development in humans and mice that lack 5a-reductase type II enzyme.(19,20) Epithelial-cell differentiation including ductal branching, canalisation and basal cell and luminal cell formation is regulated by paracrine influences from the urogenital mesenchym…”
Integrative and Analytical Review of the 5-Alpha-Reductase Type 2 Deficiency Worldwide
Batista, R. L., & Mendonca, B. B. (2020) · The Application of Clinical Genetics · doi:10.2147/tacg.s198178 · Cited by 63
Wiebe, J. P., & Lewis, M. J. (2003) · BMC Cancer · doi:10.1186/1471-2407-3-9 · Cited by 68
Early diagnosis and management of 5 alpha-reductase deficiency.
Odame, I., Donaldson, M., Wallace, A. M., Cochran, W., & Smith, P. J. (1992) · Archives of Disease in Childhood · doi:10.1136/adc.67.6.720 · Cited by 58
Martini, L., Celotti, F., & Melcangi, R. C. (1996) · Cellular and Molecular Neurobiology · doi:10.1007/bf02088095 · Cited by 58
“In this context, it is important to recall that, in rats and in men, two 5a-reductases have been recently cloned respectively from the prostate and from the liver (Andersson and Russell, 1990; Andersson et al., 1991).”
5α-Reductases in human physiology: an unfolding story
Traish, A. M. (2012) · Endocrine Practice · doi:10.4158/ep12108.ra · Cited by 57
5-α-Reductase type 2 deficiency: is there a genotype-phenotype correlation? A review
Avendaño, A., Paradisi, I., Cammarata‐Scalisi, F., & Callea, M. (2018) · HORMONES · doi:10.1007/s42000-018-0013-9 · Cited by 61
Falsetti, L., Gambera, A., Platto, C., & Legrenzi, L. (2000) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200001020-00003 · Cited by 63
Boudon, C., Lumbroso, S., Lobaccaro, J. M., Szarras‐Czapnik, M., Romer, T. E., Garandeau, P., Montoya, P., & Sultan, C. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.7.2149 · Cited by 63
Characterization of the 5α-Reductase-3α-Hydroxysteroid Dehydrogenase Complex in the Human Brain1
Steckelbroeck, S., Watzka, M., Reichelt, R., Hans, V. H. J., Stoffel-Wagner, B., Heidrich, D. D., Schramm, J., Bidlingmaier, F., & Klingmüller, D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7325 · Cited by 50
“reductase (type 1 and 2) with differential tissue distribution and biochemical properties have been identified (20, 21 ).”
BackgroundInfluential5α-Reduced glucocorticoids: a story of natural selection
Nixon, M., Upreti, R., & Andrew, R. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0318 · Cited by 69
KIMURA, Y., Suzuki, T., Kaneko, C., Darnel, A. D., Akahira, J., Ebina, M., Nukiwa, T., & Sasano, H. (2003) · Clinical Science · doi:10.1042/cs20030236 · Cited by 55
Matsui, D., Sakari, M., Sato, T., Murayama, A., Takada, I., Kim, M.-S., Takeyama, K.-I., & Kato, S. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.6.1387 · Cited by 58
“contained an ORF that encoded a putative 254 amino acid protein that showed high similarity to rat (94.9%) and human (75.7%) 5α-R2 sequences (Fig. 1A and B) ( 1 ).”
BackgroundMethodInfluentialTestosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts
́los, S. D., Carsol, J.-L., Ghazarossian, E., Raynaud, J., & Martin, P. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00184-0 · Cited by 55
Blanchard, P.-G., & Luu-The, V. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0144 · Cited by 55
“…et al. 1991, Rheaume et al. 1992), types 1 to 12 17b-HSDs (Peltoketo et al. 1988, Luu The et al. 1989), as well as types 1 and 2 5a-reductases (Andersson et al. 1991, Labrie et al. 1992), and 3a-HSDs (Cheng et al. 1991, Dufort et al. 2001) advocate for the existence of a local biosynthesis…”
BackgroundLevy, M. A., Brandt, M. A., Sheedy, K. M., Dinh, J. T., Holt, D. A., Garrison, L. M., Bergsma, D. J., & Metcalf, B. W. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90145-7 · Cited by 54
Cations Inhibit Specifically Type I 5α-Reductase Found in Human Skin
Sugimoto, Y., López-Solache, I., Labrie, F., & Luu-The, V. A. N. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12606985 · Cited by 53
Uniparental Disomy in Steroid 5 -Reductase 2 Deficiency
Chávez, B. A., Valdez, E., & Vilchis, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6786 · Cited by 53
Vilchis, Méndez, Canto, Lieberman, & Chávez (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00941.x · Cited by 54
“Molecular genetic evidence such as gene deletions, point mutations and site-directed mutagenesis have demonstrated that the 5a-reductase-type 2 gene (SRD5A2), located in 2p23, is the speci®c locus for 5a-reductase de®ciency (Andersson et al., 1991; Russell & Wilson, 1994; Wigley et al., 1994).”
BackgroundStructural Characterization and Expression of the Human Dehydroepiandrosterone Sulfotransferase Gene
LUU-THE, V., DUFORT, I., PAQUET, N., REIMNITZ, G., & LABRIE, F. (1995) · DNA and Cell Biology · doi:10.1089/dna.1995.14.511 · Cited by 53
Hackel, C., de Oliveira, L. E. C., Ferraz, L. F. C., Tonini, M. M. O., da Silva, D. N., Toralles, M. B. P., Stuchi-Perez, E. G., & Guerra‐Júnior, G. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0651-7 · Cited by 52
EPIDEMIOLOGY AND NATURAL HISTORY OF BENIGN PROSTATIC HYPERPLASIA
Guess, H. A. (1995) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)00662-5 · Cited by 52
5α-Reduced Glucocorticoids, Novel Endogenous Activators of the Glucocorticoid Receptor
McInnes, K. J., Kenyon, C. J., Chapman, K. E., Livingstone, D. E. W., Macdonald, L. J., Walker, B. R., & Andrew, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402822200 · Cited by 52
Androgens in prostate cancer: A tale that never ends
Hou, Z., Huang, S., & Li, Z. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.010 · Cited by 58
Non-neoplastic diseases of the testis
Nistal, M., & Paniagua, R. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-01970-5.50014-2 · Cited by 61
MALE SEX DETERMINATION: Current Concepts of Male Sexual Differentiation
Gustafson, M. L., & Donahoe, P. K. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.505 · Cited by 59
Ogino, Y., Suzuki, K., Haraguchi, R., SATOH, Y., Dollé, P., & Yamada, G. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03983.x · Cited by 53
Genetic Analysis of Androgen Receptors in Development and Disease
Brinkmann, A. O., & Trapman, J. (1999) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60115-5 · Cited by 56
Human Genital Melanocytes as Androgen Target Cells
Tadokoro, T., Itami, S., Hosokawa, K., Terashi, H., & Takayasu, S. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12336630 · Cited by 54
Tavani, A., Longoni, E., Bosetti, C., Maso, L. D., Polesel, J., Montella, M., Ramazzotti, V., Negri, E., Franceschi, S., & Vecchia, C. L. (2005) · European Urology · doi:10.1016/j.eururo.2005.11.027 · Cited by 52
PELLETIER, G., LUU-THE, V., HUANG, X.-F., LAPOINTE, H., & LABRIE, F. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)62961-6 · Cited by 49
The Molecular Basis of 5α-Reductase Type 2 Deficiency
Batista, R. L., & Mendonca, B. B. (2022) · Sexual Development · doi:10.1159/000525119 · Cited by 48
Androgenetic alopecia as an early marker of benign prostatic hyperplasia
Arias‐Santiago, S., Arrabal‐Polo, M. Á., Buendía‐Eisman, A., Arrabal-Martı́n, M., Gutiérrez‐Salmerón, M. T., Girón‐Prieto, M. S., Jiménez-Pacheco, A., Calonje, J. E., Naranjo‐Sintes, R., Zuluaga‐Gómez, A., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.12.023 · Cited by 47
Tian, G., Stuart, J. D., Moss, M. L., Domanico, P. L., Bramson, H. N., Patel, I. R., Kadwell, S. H., Overton, L. K., & Kost, T. A. (1994) · Biochemistry · doi:10.1021/bi00174a041 · Cited by 47
Molecular Characterization of 6 Unrelated Italian Patients With 5α‐Reductase Type 2 Deficiency
Baldinotti, F., Majore, S., Fogli, A., Marrocco, G., Ghirri, P., Vuerich, M., Tumini, S., Boscherini, B., Vetri, M. G., Scommegna, S., et al. (2007) · Journal of Andrology · doi:10.2164/jandrol.107.002592 · Cited by 49
19-Nor-10-azasteroids: A Novel Class of Inhibitors for Human Steroid 5α-Reductases 1 and 2
Guarna, A., Belle, C., Machetti, F., Occhiato, E. G., Payne, A. H., Cassiani, C., Comerci, A., Danza, G., Bellis, A. D., Dini, S., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960807v · Cited by 46
Habib, F. K., Ross, M., Bayne, C. W., Grigor, K. M., Buck, A. C., Bollina, P. R., & Chapman, K. E. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560509 · Cited by 46
Viger, R. S., & Robaire, B. (1996) · Journal of Andrology · doi:10.1002/j.1939-4640.1996.tb00583.x · Cited by 50
Luu-The, V., Pelletier, G., & Labrie, F. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.01.003 · Cited by 52
Vilchis, F., Valdez, E., Ramos, L., García, R., Gómez, R., & Chávez, B. A. (2008) · Journal of Human Genetics · doi:10.1007/s10038-008-0274-2 · Cited by 44
“Data from previous studies have shown that single base mutations or the complete deletion of SRD5A2 results in steroid 5a-reductase 2 deficiency, a rare disorder of sexual development (Andersson et al. 1991; Wilson et al. 1993; Russell et al. 1994).”
Dai, C. S., Chung, Y.-M., Kovac, E. Z., Zhu, Z., Li, J., Magi‐Galluzzi, C., Stephenson, A. J., Klein, E. A., & Sharifi, N. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1313 · Cited by 43
Finasteride, a Type 2 5α-reductase inhibitor, in the treatment of men with androgenetic alopecia
Kaufman, K. D., & Dawber, R. P. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.4.403 · Cited by 42
PNU 157706, a novel dual type I and II5α-reductase inhibitor
di Salle, E., Giudici, D., Radice, A., Zaccheo, T., Ornati, G., Nesi, M., Panzeri, A., Délos, S., & Martin, P. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00158-1 · Cited by 43
Genetic Diseases of Steroid Metabolism
(1994) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)61147-4 · Cited by 43
Samson, M., Labrie, F., Zouboulis, C. C., & Luu-The, V. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.225 · Cited by 42
Androgen Physiology: Receptor and Metabolic Disorders
McEwan, I. J., & Brinkmann, A. O. (2016) · Cited by 46
Perspective: Reproductive Tract Development--New Discoveries and Future Directions
MacLaughlin, D. T., Teixeira, J. M., & Donahoe, P. K. (2001) · Endocrinology · doi:10.1210/endo.142.6.8262 · Cited by 43
McCoy, J. A., Parrott, B. B., Rainwater, T. R., Wilkinson, P. M., & Guillette, L. J. (2015) · Reproduction · doi:10.1530/rep-15-0155 · Cited by 44
“The pivotal role of gonadal hormones in the establishment and maintenance of sexual dimorphism is well documented (Meyer et al. 1975, McEwen et al. 1977, Andersson et al. 1991).”
BackgroundLou, Y., Murtola, T. J., & Tuohimaa, P. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.01.024 · Cited by 41
Vilchis, F., Ramos, L., Méndez, J. P., Benavides, S., Canto, P., & Chávez, B. A. (2010) · Journal of Andrology · doi:10.2164/jandrol.109.009407 · Cited by 40
A new deletion of the 5α‐reductase type 2 gene in a Turkish family with 5α‐reductase deficiency
Boudon, C., Lobaccaro, J. A., Lumbroso, S., Ösgur, G., Öçal, G., Belon, C., & Sultan, C. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01913.x · Cited by 42
Oxidation of Dihydrotestosterone by Human Cytochromes P450 19A1 and 3A4
Cheng, Q., Sohl, C. D., Yoshimoto, F. K., & Guengerich, F. P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.390047 · Cited by 40
“Men with genetic deficiency of steroid 5 -reductase Type 2 show a syndrome termed pseudohermaphroditism (25).”
BackgroundDiagnosis and Treatment of Disorders of Sexual Development
Rey, R. A., & Josso, N. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00119-0 · Cited by 40
Lan, Z., Palladino, M. A., Rudolph, D. B., Labus, J. C., & Hinton, B. T. (1997) · Biology of Reproduction · doi:10.1095/biolreprod57.1.186 · Cited by 40
Expression of 5α-Reductase in the Human Temporal Lobe of Children and Adults1
Stoffel-Wagner, B., Watzka, M., Steckelbroeck, S., Wickert, L., Schramm, J., Romalo, G., Klingmüller, D., & Schweikert, H.-U. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5157 · Cited by 36
Differential expression of 5-alpha reductase isozymes in the prostate and its clinical implications
Niu, Y.-N., Wang, K., Fan, D., Jin, S., & Xing, N. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.123664 · Cited by 48
Provost, P. R., Blomquist, C. H., Drolet, R., Flamand, N., & Tremblay, Y. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8764 · Cited by 44
Bumke-Vogt, C., Bahr, V, Diederich, S., Herrmann, S., Anagnostopoulos, I., Oelkers, W., & Quinkler, M. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750349 · Cited by 40
“... for 17-hydroxylation, 17hydroxylase/17,20-lyase (P450c17 or CYP17) (Chung et al. 1987), for 20-reduction, 20-HSD (aldo-keto reductase AKR1C1) (Nishizawa et al. 2000), 3-HSD type 3 (AKR1C2) (Shiraishi et al. 1998), prostaglandin F synthase (PGFS, AKR1C3) (Suzuki-Yamamoto et al. 1999), and 17-HSD type 5 (Dufort et a…”
Ranjan, M., Diffley, P. E., Stephen, G., Price, D. E., Walton, T. J., & Newton, R. P. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01627-2 · Cited by 40
Evidence that Androgens Regulate Early Developmental Events, Prior to Sexual Differentiation
Goldman-Johnson, D. R., de Kretser, D. M., & Morrison, J. R. (2007) · Endocrinology · doi:10.1210/en.2007-1123 · Cited by 42
Weißer, H., Tunn, S., Debus, M., & Krieg, M. (1994) · Steroids · doi:10.1016/0039-128x(94)90016-7 · Cited by 38
Öçal, G., Adıyaman, P., Berberoğlu, M., Çetinkaya, E., Akar, N., Uysal, A. R., Duman, T., Evliyaoğlu, O., Aycan, Z., Lumbrasso, S., et al. (2002) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2002.15.4.411 · Cited by 37
Söderström, T. G., Bjelfman, C., Brekkan, E., Ask, B., Egevad, L., Norlén, B. J., & Rane, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7224 · Cited by 37
Melcangi, R. C., Martini, L., & Galbiati, M. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00060-6 · Cited by 39
Gillespie, C. F., Almli, L. M., Smith, A. K., Bradley, B., Kerley, K., Crain, D. F., Mercer, K. B., Weiss, T., Phifer, J., Tang, Y., et al. (2013) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32147 · Cited by 34
“Clinical studies conducted with 5aRD2 deficient pseudohermaphrodite patients have demonstrated the critical role of 5aRD2 in the production ofDHT required for virilization during development and cortisolmetabolism [Peterson et al., 1985; Andersson et al., 1991].”
BackgroundSharifi, N., McPhaul, M. J., & Auchus, R. J. (2010) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181ff6bb8 · Cited by 39
Steroidogenic Isoenzymes in Human Hair and Their Potential Role in Androgenetic Alopecia
Hoffmann, R. (2003) · Dermatology · doi:10.1159/000068475 · Cited by 36
“but without etiologic characterization which was not possible at that time. In 1974, it became clear that these individuals lack functional 5α-R, and today we know that specifically the type 2 5α-R is absent [”
BackgroundHiort, O., Sinnecker, G. H. G., Willenbring, H., Lehners, A., Zollner, A. N., & Struve, D. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.9.3415 · Cited by 36
Maïmoun, L., Philibert, P., Cammas, B., Audran, F., Pienkowski, C., Kurtz, F., Heinrich, C., Cartigny, M., & Sultan, C. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2009.01036.x · Cited by 36
Sato, Sonoda, Itami, & Takayasu (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02504.x · Cited by 36
Endocrine properties of the testosterone 5α-reductase inhibitor turosteride (FCE 26073)
di Salle, E., Briatico, G., Giudici, D., Ornati, G., & Panzeri, A. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90151-1 · Cited by 37
Méndez, J. P., Ulloa‐Aguirre, A., Imperato‐McGinley, J., Brugmann, A., Delfin, M., Chávez, B. A., Shackleton, C. H. L., Kofman‐Alfaro, S., & Pérez‐Palacios, G. (1995) · Journal of Endocrinological Investigation · doi:10.1007/bf03347803 · Cited by 35
Obeid, J. (1993) · Molecular Endocrinology · doi:10.1210/me.7.2.154 · Cited by 34
Tartagni, M. V., Alrasheed, H. H., Damiani, G. R., Montagnani, M., Salvia, M. A. D., Pergola, G. D., Tartagni, M., & Loverro, G. (2014) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2013.09.010 · Cited by 38
Achermann, J. C., & Hughes, I. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00023-7 · Cited by 40
Molecular Basis of Steroid Action in the Prostate.
Zhu, Y. (2005) · PubMed · doi:10.1901/jaba.2005.1-27 · Cited by 45
“5α-reductase-2 deficiency syndrome is an inherited autosomal recessive disease resulting from mutations in the 5α-reductase-2 gene (40).”
BackgroundLerner, A., Owens, L. A., Coates, M., Simpson, C., Poole, G., Velupillai, J., Liyanage, M., Christopoulos, G., Lavery, S. A., Hardy, K., et al. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.02.015 · Cited by 34
“SRD5A1 is one 387 of three 5α reductase enzymes involved in reducing testosterone to dihydrotestosterone and 388 progesterone to dihydroprogesterone (Andersson et al. 1991).”
BackgroundCurrent Knowledge on the Function of α-Methyl Acyl-CoA Racemase in Human Diseases
Kong, G., Lee, H., Tran, Q., Kim, C., Park, J., Kwon, S. H., Kim, S., & Park, J. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00153 · Cited by 33
“AMACR mRNA detected in cancer tissues increased by 682 times compared to normal tissue in patients with prostate cancer, and increased by 11.5 times for AR mRNA (Andersson et al., 1991; Alinezhad et al., 2016).”
BackgroundInfluentialPratis, K., O’Donnell, L., Ooi, G. T., McLachlan, R. I., & Robertson, D. M. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00139-4 · Cited by 38
Male Pseudohermaphroditism Due to 5α-Reductase 2 Deficiency: Outcome of a Brazilian Cohort
Mendonca, B. B., Inácio, M., Costa, E. M. F., Arnhold, I. J. P., Russell, D. W., & Wilson, J. D. (2003) · The Endocrinologist · doi:10.1097/01.ten.0000081675.43801.42 · Cited by 33
Self-citationAzasteroids as inhibitors of testosterone 5α-reductase in mammalian skin
Mellin, T. N., Busch, R. D., & Rasmusson, G. H. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90019-s · Cited by 33
New agents and strategies for the hormonal treatment of castration-resistant prostate cancer
Sharifi, N. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.494178 · Cited by 35
Ogino, Y., Miyagawa, S., Katoh, H., Prins, G. S., Iguchi, T., & Yamada, G. (2011) · Evolution & Development · doi:10.1111/j.1525-142x.2011.00482.x · Cited by 34
“Mutations in genes for the AR (Murakami 1987; Yeh et al. 2002; Sato et al. 2003) or for androgen synthetic enzymes (Andersson et al. 1991; Wilson 1992) result in abnormalities in male sexual development including hypospadias and cryptorchidism.”
BackgroundRECENT ADVANCES IN THE MEDICAL MANAGEMENT OF PROSTATE CANCER
Kirby, R. S. (1996) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1996.tb10036.x · Cited by 32
Targeting sex steroid biosynthesis for breast and prostate cancer therapy
POUTANEN, M. H., Thulin, M. H., & Härkönen, P. L. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00609-y · Cited by 32
Regional Distribution of 5α-Reductase Type 1 and Type 2 mRNA Along the Human Epididymis
Mahony, M. C., Swanlund, D. J., Billeter, M., Roberts, K. P., & Pryor, J. L. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00094-6 · Cited by 34
Shirakawa, T., Okada, H., Acharya, B., Zhang, Z., Hinata, N., Wada, Y., Uji, T., Kamidono, S., & Gotoh, A. (2003) · The Prostate · doi:10.1002/pros.10313 · Cited by 31
Hoffmann, R., & Happle, R. (1999) · Archives of Dermatological Research · doi:10.1007/s004030050390 · Cited by 31
Mechanism of action of androgen in hair follicles
Itami, S., Sonoda, T., Kurata, S., & Takayasu, S. (1994) · Journal of Dermatological Science · doi:10.1016/0923-1811(94)90040-x · Cited by 30
Genetic Analysis of the SRD5A2 Gene in Indian Patients with 5α-Reductase Deficiency
Sahu, R. P., Boddula, R., Sharma, P., Bhatia, V., Greaves, R. F., Rao, S. N., Desai, M., Wakhlu, A., Phadke, S. R., Shukla, M., et al. (2009) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2009.22.3.247 · Cited by 30
Alinezhad, S., Väänänen, R., Tong-Ochoa, N., Vertosick, E., Bjartell, A. S., Boström, P. J., Taimen, P., & Pettersson, K. S. I. (2016) · BMC Urology · doi:10.1186/s12894-016-0128-8 · Cited by 30
REYES, E. M., Camacho‐Arroyo, I., NAVA, G., & Cerbón, M. A. (1997) · Journal of Andrology · doi:10.1002/j.1939-4640.1997.tb01941.x · Cited by 34
Metadata
- Authors
- Andersson, S., Berman, D. M., Jenkins, E. P., & Russell, D. W.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Nature
- Published
- 1991-11
- Volume
- 354
- Issue
- 6349
- Pages
- 159-161
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4451825
- OpenAlex
- W2058387263
- Cited by
- 643
- References
- 29
- Citations by year
- 2026: 9 · 2025: 3 · 2024: 6 · 2023: 13 · 2022: 8 · 2021: 14 · 2020: 13 · 2019: 7 · 2018: 11 · 2017: 9 · 2016: 11 · 2015: 14 · 2014: 9 · 2013: 13 · 2012: 15
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL020948)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Health Sciences › Medicine › Urology › Urological Disorders and Treatments
- Keywords
- 5-alpha-reductase deficiency, 46,XY disorders of sex development, dihydrotestosterone, androgen action, male sexual differentiation, gene deletion, cDNA cloning, isozymes, prostate
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Genes, Humans, Hydrogen-Ion Concentration, Isoenzymes, Molecular Sequence Data, Disorders of Sex Development, 3-Oxo-5-alpha-Steroid 4-Dehydrogenase, Blotting, Southern, Sequence Alignment, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.